Clinical Trials Directory

Trials / Completed

CompletedNCT02609295

Effects of α-linolenic Acid Supplementation on Hemostasis in Nondiabetic and Hypercholesterolemic Subjects

Effects of α-linolenic Acid Supplementation in the Form of Perilla Oil on Collagen-epinephrine Closure Time, Activated Partial Thromboplastin Time and Lp-PLA2 Activities in Nondiabetic and Hypercholesterolemic Subjects

Status
Completed
Phase
Phase 3
Study type
Interventional
Enrollment
86 (actual)
Sponsor
Yonsei University · Academic / Other
Sex
All
Age
40 Years – 68 Years
Healthy volunteers
Accepted

Summary

This study evaluates whether ALA intake alters total cholesterol and homeostatic factors and the relationship between these alteration and lipoprotein associated phospholipase A2 (Lp-PLA2) activity.

Detailed description

An 8-week, randomized, double-blind, placebo-controlled study was conducted with 86 nondiabetic and borderline-to-moderate hypercholesterolemic (200mg/dL ≤ serum cholesterol ≤ 300mg/dL) subjects, not taking any medications and supplements to affect lipid metabolism, platelet function and inflammation, divided into two groups: an α-linolenic acid (ALA) group \[1.2 g (two capsules) of perilla oil daily; 497 mg ALA\] and a placebo group (1.2 g of medium-chain triglyceride oil daily).

Conditions

Interventions

TypeNameDescription
DIETARY_SUPPLEMENTPlacebo1.2 g (two capsules) of medium-chain triglyceride (MCT) oil
DIETARY_SUPPLEMENTALA group1.2 g (two capsules) of perilla oil

Timeline

Start date
2015-02-01
Primary completion
2015-08-01
Completion
2015-08-01
First posted
2015-11-20
Last updated
2016-01-22

Locations

1 site across 1 country: South Korea

Source: ClinicalTrials.gov record NCT02609295. Inclusion in this directory is not an endorsement.

Effects of α-linolenic Acid Supplementation on Hemostasis in Nondiabetic and Hypercholesterolemic Subjects (NCT02609295) · Clinical Trials Directory